You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-MEKK (MAP3K)-GS-444217
GS-444217

Chemical Structure : GS-444217

CAS No.: 1262041-49-5

GS-444217 (GS444217)

Catalog No.: PC-35427Not For Human Use, Lab Use Only.

GS-444217 (GS444217) is a potent, selective, ATP-competitive, orally available inhibitor of ASK1 with Kd/IC50 of 4.1/2.87 nM.

Packing Price Stock Quantity
10 mg $138 In stock
25 mg $238 In stock
50 mg $398 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

GS-444217 (GS444217) is a potent, selective, ATP-competitive, orally available inhibitor of ASK1 with Kd/IC50 of 4.1/2.87 nM。
GS-444217 displays >53-fold selectivity over DYRK1A and 104-fold over RSK4 in a panel of 442 kinases。
GS-444217 strongly suppresses the activation of ASK1, p38, and JNK in the kidney resulting in decreased death of parenchymal cells, inflammation, and fibrosis。
GS-444217 abrogates p38 MAPK activation in diabetic kidneys but has no effect upon hypertension in Nos3(-/-) mice。
GS-444217 dose dependently reduced pulmonary arterial pressure and reduced RV hypertrophy in pulmonary arterial hypertension (PAH) models。
GS-444217 also reduces the progressive inflammation and fibrosis in the kidney and halted decline of glomerular filtration rate in models of kidney disease, causes regression of fibrosis combined with RAS inhibitor enalapril.

Physicochemical Properties

M.Wt 411.469
Formula C23H21N7O
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-(4-cyclopropyl-1H-imidazol-1-yl)-N-(3-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)phenyl)picolinamide

References

1. Liles JT, et al. J Clin Invest. 2018 Jul 19. pii: 99768. doi: 10.1172/JCI99768.

2. Tesch GH, et al. Diabetes. 2015 Nov;64(11):3903-13.

3. Budas GR, et al. Am J Respir Crit Care Med. 2018 Feb 1;197(3):373-385.

4. Amos LA, et al. J Cell Mol Med. 2018 Jul 11. doi: 10.1111/jcmm.13705.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: